ANXA2 and neoplasm: As a receptor for plasminogen and tPA, ANXA2 promotes plasmin generation, resulting in degradation of extracellular matrix (ECM), which facilitates cellular migration, tumor cell invasion and neoangiogenesis (Andreasen et al., 2000; Xu et al., 2015; Sharma, 2019).